5th International Workshop on Chronic Lymphocytic Leukemia.
In the past few years important advances have been made in our understanding of the biology and natural history of CLL; also, new strategies and agents offer promise in the treatment of this form of leukemia. Now, patients can be treated on a more rationale basis and with real prospects for a sustained control of their disease, and improved quality of life. Hopefully, progresses in CLL will continue to accumulate in the coming years.
Montserrat
E
E
Postgraduate School of Hematology, Farreras Valenti, Hospital Clínic, Barcelona, Spain.
Binet
J L
JL
Catovsky
D
D
Dighiero
G
G
Gale
R P
RP
Rai
K R
KR
Rozman
C
C
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D015322:Gene Rearrangement, B-Lymphocyte; D006133:Growth Substances / Q000378:metabolism; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D051379:Mice; D011379:Prognosis
D006133:Growth Substances